Literature DB >> 25268855

Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.

Laura Y Wang1, Frank L Palmer, Iain J Nixon, Dorothy Thomas, Jatin P Shah, Snehal G Patel, R Michael Tuttle, Ashok R Shaha, Ian Ganly.   

Abstract

BACKGROUND: The aim of our study was to determine central compartment lymph node (LN) characteristics predictive of outcomes in patients with differentiated thyroid cancer (DTC) and pathologically confirmed positive central LNs, in the absence of lateral neck disease or distant metastases at presentation.
METHODS: An institutional database of 3664 previously untreated patients with DTC operated between 1986 and 2010 was reviewed. Six hundred patients with central compartment nodal disease on histopathology were identified. Patient demographics, number of positive LNs, size of largest LN, and presence of extranodal spread (ENS) were recorded for each patient. Variables predictive of recurrence-free survival (RFS) were identified using the Kaplan-Meier method. Univariate analysis was carried out by the log-rank test and multivariable analysis was carried out using cox proportional hazard model.
RESULTS: The median age of the cohort was 41 years (range 12-91 years). The median follow-up was 61 months (range 1-330 months). Neck recurrence occurred in 43 patients. Recurrence occurred in the central neck in 11 patients, lateral neck in 27 patients, and both compartments in five patients. Factors predictive of neck RFS on univariate analysis were higher T stage (p=0.007), increased number of positive LNs, increased LN diameter, and presence of ENS (p=0.001). Multivariable analysis of LN characteristics showed that the only statistically significant predictor of neck recurrence was the presence of ENS. Neck RFS at five years for patients with and without ENS was 84.7% and 94.5% respectively (p=0.001).
CONCLUSION: The LN feature most predictive of neck recurrence appears to be the presence of ENS in the positive central neck.

Entities:  

Mesh:

Year:  2014        PMID: 25268855     DOI: 10.1089/thy.2014.0256

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  15 in total

1.  Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.

Authors:  Laura Y Wang; Frank L Palmer; Iain J Nixon; R Michael Tuttle; Jatin P Shah; Snehal G Patel; Ashok R Shaha; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

2.  Role of RAI in the management of incidental N1a disease in papillary thyroid cancer.

Authors:  Laura Y Wang; Frank L Palmer; Jocelyn C Migliacci; Iain J Nixon; Ashok R Shaha; Jatin P Shah; Robert Michael Tuttle; Snehal G Patel; Ian Ganly
Journal:  Clin Endocrinol (Oxf)       Date:  2015-07-03       Impact factor: 3.478

3.  Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.

Authors:  J-W Feng; X-H Yang; B-Q Wu; D-L Sun; Y Jiang; Z Qu
Journal:  Clin Transl Oncol       Date:  2019-03-16       Impact factor: 3.405

4.  Pathologic features of metastatic lymph nodes identified from prophylactic central neck dissection in patients with papillary thyroid carcinoma.

Authors:  Hyoung Shin Lee; Chanwoo Park; Sung Won Kim; Woong Jae Noh; Soo Jin Lim; Bong Kwon Chun; Beom Su Kim; Jong Chul Hong; Kang Dae Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-12       Impact factor: 2.503

Review 5.  Nodal metastases in thyroid cancer: prognostic implications and management.

Authors:  Laura Y Wang; Ian Ganly
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

6.  Frozen section analysis of central lymph nodes in papillary thyroid cancer: the significance in determining the extent of surgery.

Authors:  Min Jhi Kim; Hee Jun Kim; Cheong Soo Park; Bup-Woo Kim
Journal:  Gland Surg       Date:  2022-04

7.  Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma.

Authors:  Ji Min Na; Dong Chul Kim; Dae Hyun Song; Hyo Jung An; Hyun Min Koh; Jeong-Hee Lee; Jong Sil Lee; Jung Wook Yang; Min Hye Kim
Journal:  J Pathol Transl Med       Date:  2022-05-11

Review 8.  Management of the Neck in Well-Differentiated Thyroid Cancer.

Authors:  Panagiotis Asimakopoulos; Ashok R Shaha; Iain J Nixon; Jatin P Shah; Gregory W Randolph; Peter Angelos; Mark E Zafereo; Luiz P Kowalski; Dana M Hartl; Kerry D Olsen; Juan P Rodrigo; Vincent Vander Poorten; Antti A Mäkitie; Alvaro Sanabria; Carlos Suárez; Miquel Quer; Francisco J Civantos; K Thomas Robbins; Orlando Guntinas-Lichius; Marc Hamoir; Alessandra Rinaldo; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-11-14       Impact factor: 5.075

9.  miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway.

Authors:  Shuang Yu; Siting Cao; Shubin Hong; Xiaorong Lin; Hongyu Guan; Shuwei Chen; Quan Zhang; Weiming Lv; Yanbing Li; Haipeng Xiao
Journal:  Ann Transl Med       Date:  2019-11

10.  The prognostic value of regional lymph node metastases in patients of Guangdong Province, China with differentiated thyroid cancer: A multicenter retrospective clinical study.

Authors:  Lin-Yun He; Wei-Wei Wang; Balde Alpha Ibrahima; Shuai Han; Zhou Li; Zhai Cai; Miao-Liang Chen; Bao-Zhu Chen; Hui-Shi Tan; Hai-Shan Zeng; Xiao-Li Dai; Min-Wei Zhou; Gang-Qing Zhang; Guo-Xin Li
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.